AU2016295329A1 - Methods and systems for endometrial treatment - Google Patents

Methods and systems for endometrial treatment Download PDF

Info

Publication number
AU2016295329A1
AU2016295329A1 AU2016295329A AU2016295329A AU2016295329A1 AU 2016295329 A1 AU2016295329 A1 AU 2016295329A1 AU 2016295329 A AU2016295329 A AU 2016295329A AU 2016295329 A AU2016295329 A AU 2016295329A AU 2016295329 A1 AU2016295329 A1 AU 2016295329A1
Authority
AU
Australia
Prior art keywords
endometrial
stem cell
tissue
dna
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016295329A
Other languages
English (en)
Inventor
Piraye Yurttas Beim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celmatix Inc
Original Assignee
Celmatix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celmatix Inc filed Critical Celmatix Inc
Publication of AU2016295329A1 publication Critical patent/AU2016295329A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3882—Hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/24—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the genital tract, from non-germinal gonad cells
    • C12N2506/243—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the genital tract, from non-germinal gonad cells from cells of the female genital tract cells, from non-germinal ovarian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2016295329A 2015-07-17 2016-07-13 Methods and systems for endometrial treatment Abandoned AU2016295329A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562193903P 2015-07-17 2015-07-17
US62/193,903 2015-07-17
PCT/US2016/042070 WO2017015023A2 (en) 2015-07-17 2016-07-13 Methods and systems for endometrial treatment

Publications (1)

Publication Number Publication Date
AU2016295329A1 true AU2016295329A1 (en) 2018-02-01

Family

ID=57774794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016295329A Abandoned AU2016295329A1 (en) 2015-07-17 2016-07-13 Methods and systems for endometrial treatment

Country Status (6)

Country Link
US (1) US20170014456A1 (enExample)
EP (1) EP3325028A4 (enExample)
JP (1) JP2018525356A (enExample)
AU (1) AU2016295329A1 (enExample)
CA (1) CA2992086A1 (enExample)
WO (1) WO2017015023A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109381743A (zh) * 2017-08-09 2019-02-26 深圳先进技术研究院 3d打印人造子宫内膜及其制备方法和应用
EP3888666A1 (en) * 2020-04-03 2021-10-06 InoCells B.V. Composition
CN118526567A (zh) * 2022-06-07 2024-08-23 广州金天芳颜化妆品有限公司 基于子宫内膜干细胞的阴道修复凝胶、制备方法及应用
CN117801091B (zh) * 2023-12-28 2024-05-31 广东圆康再生医学科技开发有限公司 一种子宫内膜干细胞在子宫内膜修复中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498498B2 (en) * 2013-03-15 2016-11-22 Avita International Ltd. Adipose tissue mesenchymal stem cells and methods of use to treat or inhibit uterine disorders
KR101533789B1 (ko) * 2013-10-01 2015-07-02 (주)마리아 바이오텍 자궁내막조직유래 간엽줄기세포를 유효성분으로 함유하는 임신 촉진용 조성물

Also Published As

Publication number Publication date
WO2017015023A2 (en) 2017-01-26
JP2018525356A (ja) 2018-09-06
CA2992086A1 (en) 2017-01-26
EP3325028A2 (en) 2018-05-30
US20170014456A1 (en) 2017-01-19
EP3325028A4 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
RU2770879C2 (ru) Полногеномные библиотеки отдельных клеток для бисульфитного секвенирования
JP5916166B2 (ja) 組織試料中の核酸の局在化された検出、又は空間的検出のための方法及び生成物
US20200017912A1 (en) Methods and systems for assessing infertility and related pathologies
Ginsberg RNA amplification strategies for small sample populations
RU2753883C2 (ru) Набор зондов для анализа образцов днк и способы их использования
JP6765960B2 (ja) 胚の品質を決定するための方法
KR20190034164A (ko) 단일 세포 전체 게놈 라이브러리 및 이의 제조를 위한 조합 인덱싱 방법
JP2021176302A (ja) 腫瘍のディープシークエンシングプロファイリング
JP2025108660A (ja) ハイスループット単一細胞ライブラリー、並びに製造方法及び使用方法
US20170014456A1 (en) Methods and systems for endometrial treatment
JP2023153732A (ja) Ｄｎａ配列の標的特異的ｒｎａ転写のための方法
CN116391046A (zh) 通过寡杂交和基于pcr扩增进行核酸检测的方法
WO2017181670A1 (zh) 一种从核酸样品富集目标序列核酸的方法
WO2019116800A1 (ja) 単一細胞の網羅的３'末端遺伝子発現解析法
JP2026067857A (ja) ３’オーバーハングを修復する方法
US20070238111A1 (en) Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
RU2838946C2 (ru) Высокопроизводительные библиотеки одиночных клеток и способы получения и использования
Sarker et al. Directed isolation and mapping of microsatellites from swine Chromosome 1q telomeric region through microdissection and RH mapping
WO2025138284A1 (zh) 用于检测核酸空间信息的阵列及检测方法
US20180245037A1 (en) Non-Invasive Methods for Assessing Genetic Integrity of Pluripotent Stem Cells
EP1527201B1 (en) Analysis of biological samples
HK40068328A (en) High-throughput single-cell libraries and methods of making and of using
van Roessel A Cell-Specific Analysis of Gene Expression in the Neural Crest of Zebrafish
HK40027672A (en) Single cell whole genome libraries for methylation sequencing
EP1525326A1 (en) Analysis of biological samples

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application